CMR Surgical key facts
as of Oct 2026- Developer of surgical robotic systems designed to bring the benefits of minimal access surgery to all patients.
- CMR Surgical is valued at approximately $2.7B as of Oct 2026 (last reported valuation).
- It has raised $1.4B; the latest was Debt - General ($11.8M) in Dec 2025.
- Notable investors include SoftBank Investment Advisers, SoftBank Group, Lightrock, Chimera Capital, Ally Bridge Group — 26 tracked in total.
- Status: Privately Held (backing).
CMR Surgical's last reported valuation, Jun 2021. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch CMR Surgical: the Monday email on marks, rounds and moves
CMR Surgical funding rounds
No funding rounds for CMR Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs CMR Surgical
26+CMR Surgical valuation
CMR Surgical's last reported valuation was $2.7 billion in Jun 2021. No priced round, secondary trade or fund mark has surfaced since.
CMR Surgical investors
26 investors are on record for CMR Surgical, including SoftBank Investment Advisers, SoftBank Group, Lightrock and Chimera Capital.
About CMR Surgical
Developer of surgical robotic systems designed to bring the benefits of minimal access surgery to all patients. The company's systems are making minimal access surgery universally accessible and affordable by expanding the range of procedures that can be performed by robots, enabling surgeons to access three-dimensional, high-definition imagery along with feedback during the operation.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2014
- Employees
- 642
- Website
- cmrsurgical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.